Despite low volatility in the domestic stock markets over the past few months, investors are expected to tread cautiously ...

Domestic brokerage Nuvama Institutional Equities warned that Nifty 50's decline is due to weak earnings and high valuations, ...

India's defence sector is set for significant growth, with exports projected to reach Rs 203 billion by FY25 and European ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

While the central bank's easing measures may provide short-term relief, global uncertainties—such as a US growth slowdown and ...

Given the persistent selling by global funds, Nifty recorded five consecutive months of selling - the first time in three ...

India's defence sector is set for significant growth with defence exports projected to hit Rs 203 billion by FY25. European ...

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!

Explore ACME Solar's growth potential; analysts predict a 70% upside. Diversifying into nuclear energy and boosting capacity.

Citi's picks in India's asset management companies are 360 One, Nuvama and Prudent. While Aditya Birla Sun Life AMC Ltd's ...

Shares of Zee Entertainment rose on Friday after brokerage house Nuvama maintained a 'buy' rating with a target price of Rs ...